Evolent Health, Inc Class A Common Stock (EVH)

Price$2.93

Favorite Metrics

Price vs S&P 500 (26W)-72.98%

Price vs S&P 500 (4W)0.58%

Market Capitalization$327.10M

All Metrics

P/CF (Annual)8.42x

Book Value / Share (Quarterly)$3.72

P/TBV (Annual)2.56x

Revenue Growth (3Y)11.54%

Cash Flow / Share (Quarterly)$0.04

Price vs S&P 500 (YTD)-33.14%

Gross Margin (TTM)21.31%

Net Profit Margin (TTM)-28.49%

EPS (TTM)$-4.76

10-Day Avg Trading Volume3.12M

EPS Excl Extra (TTM)$-4.76

Revenue Growth (5Y)15.20%

EPS (Annual)$-4.68

ROI (Annual)-38.57%

Gross Margin (Annual)21.31%

Net Profit Margin (5Y Avg)-8.44%

Cash / Share (Quarterly)$1.36

Revenue Growth QoQ (YoY)-27.50%

ROA (Last FY)-28.14%

Revenue Growth TTM (YoY)-26.56%

EBITD / Share (TTM)$-2.74

ROE (5Y Avg)-30.13%

Operating Margin (TTM)-22.84%

Cash Flow / Share (Annual)$0.04

P/B Ratio0.79x

P/B Ratio (Quarterly)1.08x

Net Income / Employee (Annual)$-0

EV / Revenue (TTM)0.61x

Net Interest Coverage (TTM)-4.07x

ROA (TTM)-22.58%

EV / EBITDA (TTM)17.52x

EPS Incl Extra (Annual)$-4.68

Current Ratio (Annual)1.31x

Quick Ratio (Quarterly)1.27x

3-Month Avg Trading Volume3.14M

52-Week Price Return-69.23%

EV / Free Cash Flow (Annual)240.96x

Revenue / Employee (TTM)$0

Tangible BV / Share (Quarterly)$1.96

P/S Ratio (Annual)0.17x

Asset Turnover (Annual)0.99x

52-Week High$12.06

Operating Margin (5Y Avg)-6.31%

EPS Excl Extra (Annual)$-4.68

CapEx CAGR (5Y)1.42%

Tangible BV CAGR (5Y)-3.59%

26-Week Price Return-64.23%

Quick Ratio (Annual)1.27x

13-Week Price Return-27.18%

Total Debt / Equity (Annual)2.34x

Current Ratio (Quarterly)1.31x

Enterprise Value$1,145.781

Revenue / Share Growth (5Y)8.57%

Asset Turnover (TTM)0.79x

Book Value / Share Growth (5Y)-12.72%

Revenue / Employee (Annual)$0

Pretax Margin (Annual)-28.50%

Cash / Share (Annual)$1.36

3-Month Return Std Dev87.39%

Gross Margin (5Y Avg)22.03%

Net Income / Employee (TTM)$-0

ROE (Last FY)-128.74%

Net Interest Coverage (Annual)-4.07x

EPS Basic Excl Extra (Annual)$-4.68

P/FCF (TTM)6.83x

Receivables Turnover (TTM)5.18x

EV / Free Cash Flow (TTM)240.96x

Total Debt / Equity (Quarterly)2.34x

EPS Incl Extra (TTM)$-4.76

Receivables Turnover (Annual)5.18x

ROI (TTM)-29.77%

P/S Ratio (TTM)0.17x

Pretax Margin (5Y Avg)-9.83%

Revenue / Share (Annual)$16.43

Tangible BV / Share (Annual)$4.44

Forward P/E21.33x

Price vs S&P 500 (52W)-104.33%

Year-to-Date Return-29.00%

5-Day Price Return12.25%

EPS Normalized (Annual)$-4.68

ROA (5Y Avg)-7.70%

Net Profit Margin (Annual)-28.49%

Month-to-Date Return24.56%

Cash Flow / Share (TTM)$0.01

EBITD / Share (Annual)$-2.74

Operating Margin (Annual)-22.84%

LT Debt / Equity (Annual)2.34x

P/CF (TTM)8.42x

ROI (5Y Avg)-10.73%

LT Debt / Equity (Quarterly)2.34x

EPS Basic Excl Extra (TTM)$-4.76

P/TBV (Quarterly)4.32x

P/B Ratio (Annual)1.08x

Pretax Margin (TTM)-28.50%

Book Value / Share (Annual)$3.72

Price vs S&P 500 (13W)-30.04%

Beta0.47x

P/FCF (Annual)68.79x

Revenue / Share (TTM)$16.81

ROE (TTM)-60.90%

52-Week Low$2.10

Analyst Recommendations

Jan 2026

Feb 2026

Mar 2026

Apr 2026

4.26

4.20

4.15

Industry Peers — Management Services(3)

Symbol	P/E Ratio (Annual)	ROE (TTM)	Revenue Growth (5Y)	Indicated Dividend Yield (Annual)	Price
EVHEvolent Health, Inc Class A Common Stock	—	-60.90%	15.20%	—	$2.93
RTORentokil Initial plc American Depositary Shares (each representing five (5) Ordinary Shares)	36.14x	8.73%	19.77%	1.83%	$34.06
ITGartner, Inc.	15.04x	74.66%	9.65%	—	$156.23
FCFranklin Covey Company	86.99x	-4.11%	6.11%	—	$23.38

About

Evolent Health provides technology and services that enable health systems, physician organizations, and health plans to transition to value-based care models. The company delivers specialty care management across oncology, cardiology, and musculoskeletal markets, along with integrated total cost of care management and health plan administration solutions.